Literature DB >> 3979910

In vivo assessment of granulocyte migration to diseased bowel in Crohn's disease.

S H Saverymuttu, A M Peters, J P Lavender, V S Chadwick, H J Hodgson.   

Abstract

It has been suggested, on the basis of impaired granulocyte migration to skin windows, that there is a fundamental granulocyte defect in Crohn's disease. In vitro tests of granulocyte function have, however, failed to confirm this. We have studied granulocyte migration to inflamed bowel in Crohn's disease using a new approach which utilises dynamic gamma camera imaging after injection of 111In labelled autologous granulocytes. In 20 of 22 studies there was rapid migration to diseased bowel, compatible with no migration delay. Only two patients showed delays in migration of 12 and 15 minutes respectively, but neither had any clinical characteristics to distinguish them from the other 20 patients. This study shows that the majority of patients with Crohn's disease in relapse have rapid granulocyte migration to diseased bowel and provides evidence against a significant migration defect in this condition.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3979910      PMCID: PMC1432507          DOI: 10.1136/gut.26.4.378

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Defective regulation of inflammatory mediators in Hodgkin's disease. Supernormal levels of chemotactic-factor inactivator.

Authors:  P A Ward; J L Berenberg
Journal:  N Engl J Med       Date:  1974-01-10       Impact factor: 91.245

2.  Defective neutrophil chemotaxis corrected by levamisole in Crohn's disease.

Authors:  F Patrone; F Dallegri; C Sacchetti
Journal:  Acta Hepatogastroenterol (Stuttg)       Date:  1978-08

3.  Abnormalities of neutrophil function do not cause the migration defect in Crohn's disease.

Authors:  C O Moráin; A A Segal; D Walker; A J Levi
Journal:  Gut       Date:  1981-10       Impact factor: 23.059

4.  The pathogenesis of Crohn's disease.

Authors:  M Ward
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

5.  Defective neutrophil migration in sarcoidosis.

Authors:  R W Gange; M M Black; P Carrington; R McKerron
Journal:  Lancet       Date:  1977-08-20       Impact factor: 79.321

6.  Granulocyte chemotaxis in Crohn's disease.

Authors:  J Belsheim; H Gnarpe; S Persson
Journal:  Acta Chir Scand       Date:  1981

7.  Neutrophil dysfunction in Crohn's disease.

Authors:  A W Segal; G Loewi
Journal:  Lancet       Date:  1976-07-31       Impact factor: 79.321

8.  Defective regulation of chemotaxis in cirrhosis.

Authors:  E C Maderazo; P A Ward; R Quintiliani
Journal:  J Lab Clin Med       Date:  1975-04

9.  Indium-111 tagged leucocytes in the diagnosis of inflammatory bowel disease.

Authors:  A W Segal; J Ensell; J M Munro; M Sarner
Journal:  Lancet       Date:  1981-08-01       Impact factor: 79.321

10.  In vitro studies on cellular and humoral chemotaxis in Crohn's disease using the under agarose gel technique.

Authors:  R D'Amelio; P Rossi; S Le Moli; R Ricci; S Montano; F Pallone
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

View more
  16 in total

1.  Chemotactic activity in inflammatory bowel disease. Role of leukotriene B4.

Authors:  E A Lobos; P Sharon; W F Stenson
Journal:  Dig Dis Sci       Date:  1987-12       Impact factor: 3.199

2.  Polymorphonuclear leucocytes in Crohn's disease and ulcerative proctocolitis: association between enhanced adherence to nylon fibre and disease variables.

Authors:  J Cason; C C Ainley; R A Wolstencroft; R P Thompson
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

3.  Neutrophil differentiated HL-60 cells model Mac-1 (CD11b/CD18)-independent neutrophil transepithelial migration.

Authors:  Svetlana O Carrigan; Amy L Weppler; Andrew C Issekutz; Andrew W Stadnyk
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

Review 4.  Neutrophil-Epithelial Interactions: A Double-Edged Sword.

Authors:  Charles A Parkos
Journal:  Am J Pathol       Date:  2016-04-12       Impact factor: 4.307

5.  Image quality and radiopharmaceutical parameters of indium-111 granulocytes in scintigraphy of inflammatory bowel disease.

Authors:  J W Arndt; G E Crama-Bohbouth; H W Verspaget; D Blok; A S Pena; R T Tham; I T Weterman; C B Lamers; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1989

Review 6.  [Inhibition of intestinal leukotriene formation as a possible mechanism of action of sulfasalazine, 5-aminosalicylic acid and 4-aminosalicylic acid].

Authors:  B M Peskar
Journal:  Klin Wochenschr       Date:  1988-11-15

Review 7.  Chemokines in the inflammatory bowel diseases.

Authors:  R P MacDermott
Journal:  J Clin Immunol       Date:  1999-09       Impact factor: 8.317

8.  Labelled leucocyte scintigraphy in inflammatory bowel disease: clinical applications.

Authors:  M H Giaffer
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

Review 9.  The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease.

Authors:  Jennifer C Brazil; Nancy A Louis; Charles A Parkos
Journal:  Inflamm Bowel Dis       Date:  2013-06       Impact factor: 5.325

10.  Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation.

Authors:  S Nikolaus; J Bauditz; P Gionchetti; C Witt; H Lochs; S Schreiber
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.